Article -> Article Details
| Title | Animal Vaccines Market Size Global Synopsis, Future Scope, Top Key Players and Forecast to 2030 |
|---|---|
| Category | Fitness Health --> Health Articles |
| Meta Keywords | Animal Vaccines Market Size |
| Owner | Vaibhav |
| Description | |
|
Animal
Vaccines Market Size registering a CAGR of 7.50% during the forecast period
(2020 - 2030), The market was valued at USD 8,013.06 million in 2020 and
expected to reach USD 15250.5 million by 2030. The Animal Vaccines
Market Size suffered immensely because pet owners and farmers were encouraged
to keep their animals at home. They were advised against taking their pets to
the vet to get strong and effective vaccines like the Pfizer veterinary
vaccines. Growth in the veterinary/Animal Vaccines Market Size is starting to
pick up dramatically now that a vaccine for COVID-19 is being widely
administered. Demand for animal vaccines is surging because livestock on farms
around the world need these to remain healthy. Major Key
Players: Some of the key players operating in the Animal
Vaccines Market Size are Boehringer Ingelheim International GmbH (Germany),
Zoetis Inc. (US), Ceva Santé Animale (France), Merck & Co., Inc. (US),
Elanco Animal Health Incorporated (US), Virbac (France), Phibro Animal Health
Corporation (US), Hipra (Spain), Biogénesis Bagó S.A.(Argentina), Neogen
Corporation (US). Segment Analysis The global animal pharmaceuticals market is segmented into type, technology, and region. The type
segment is further segmented into porcine vaccines, poultry vaccines, livestock
vaccines, companion animal vaccines, aquacultutre vaccines. The technology
segment is segmented into Live attenuated vaccines, Inactivated vaccines,
Toxoid vaccines, Recombinant vaccines, others. Regional Analysis The global palliative care
market, based on region, has been divided into Americas, Europe, Asia-Pacific,
and Middle East & Africa. Americas dominated the global
animal vaccine market due to various factors, such as the rising prevalence of
animal diseases and the rise in pet ownership in the region. Furthermore, the
high number of veterinary clinics in the region also boosts the growth of the
market. There is an increasing prevalence of animal diseases such as foot &
mouth disease, canine parvovirus, distemper, and reproductive & respiratory
syndrome. Parvovirus infections are seen across the US and Canada. The American
Veterinary Medical Association (AVMA) reported around 118,624 veterinary
practitioners were operating in 2020. Similarly, according to the statistics
published by the Canadian Veterinary Medical Association in 2020, about 12,921
veterinarians were present in Canada. Europe accounted for a
significant share in the market owing to a high population of companion animals
in Europe, rising research and development investment, and increasing adoption
of animal vaccines. According to the Industrial Association of Pet Care
Producers, there are around 34 million pets in the UK, including dogs, cats,
small mammals, and birds. In October 2021, Boehringer Ingelheim announced an
additional 100 million EUR investment in its veterinary public health
capabilities in Lyon-Jonage, France, to aid governments and public health
organizations in managing future emerging and transboundary diseases. The
additional investment will enable the adaptation of production lines for other
emerging diseases, in particular swine and avian vaccines. Asia-Pacific is expected to
exhibit the highest CAGR during the forecast period of 2021-2030. This is due
to lucrative opportunities for players operating in the animal vaccine market,
a rise in the livestock population, and the increasing prevalence of animal
diseases in the region. There is increasing awareness about animal health in
the Asia-Pacific region. For instance, according to the report published by Pet
Fair Asia and goumin.com, the total number of pet dogs and cats in China
reached 99.15 million, with pet owners spending 29 billion US dollars in 2019.
The increasing prevalence of animal diseases such as foot and mouth disease and
avian influenza boosts the market growth in the region. Middle East & Africa is
expected to witness restricted growth compared to other regions due to limited
access and healthcare affordability. The market growth in the region is driven
by factors like the increasing incidence of zoonotic diseases and increasing
pet adoption in the region. The common zoonotic disease diagnosed in this
region is Rift Valley fever. Hence, emphasis is being put on promoting animal
health in the region and improving healthcare services for companion animals. About Market Research
Future At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services. MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions. In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members. Contact us: Market Research Future
(part of Wantstats Research and Media Private Limited), 99 Hudson Street, 5Th Floor, New York, New York 10013 United States of America +1 646 845 9312 | |